ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      85.045
      0.31%
      Bitcoin
      64,840.53
      -0.46%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ionis Pharmaceuticals Inc (IONS)

      7. Ionis Pharmaceuticals Inc (IONS) News

      IONS

      Ionis Pharmaceuticals (IONS)

      Ionis Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IONS
      DateTimeSourceHeadlineSymbolCompany
      02/07/20236:10AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      02/07/20236:07AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      02/07/20236:07AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      02/07/20236:06AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      02/07/20236:06AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      02/07/20236:05AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      02/02/20231:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      02/01/20239:05AMPR Newswire (US)Ionis announces GSK has advanced bepirovirsen into Phase 3 developmentNASDAQ:IONSIonis Pharmaceuticals Inc
      02/01/20236:05AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/31/20237:52AMDow Jones NewsIonis Gets FDA Fast-Track Designation for Olezarsen in Familial Chylomicronemia SyndromeNASDAQ:IONSIonis Pharmaceuticals Inc
      01/31/20237:05AMPR Newswire (US)Ionis receives FDA Fast Track designation for olezarsen in patients with familial chylomicronemia syndromeNASDAQ:IONSIonis Pharmaceuticals Inc
      01/26/20239:30AMPR Newswire (US)Ionis Chief Scientific Officer C. Frank Bennett, Ph.D. to receive Rainwater Prize for Outstanding Innovation in Neurodegenerative Disease ResearchNASDAQ:IONSIonis Pharmaceuticals Inc
      01/19/20236:02AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/19/20236:02AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/19/20236:02AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/09/20239:15AMGlobeNewswire Inc.Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial ReadinessNASDAQ:IONSIonis Pharmaceuticals Inc
      01/09/20239:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/09/20239:05AMPR Newswire (US)Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis' genetic medicines and commercial readinessNASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/05/20236:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IONSIonis Pharmaceuticals Inc
      01/04/20237:30AMGlobeNewswire Inc.Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO TherapiesNASDAQ:IONSIonis Pharmaceuticals Inc
      01/04/20237:05AMPR Newswire (US)Ionis to present at 41st Annual J.P. Morgan Healthcare conferenceNASDAQ:IONSIonis Pharmaceuticals Inc
      12/07/20229:36AMTipRanksBMO Capital Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)NASDAQ:IONSIonis Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IONS